Salesforce To Acquire Informatica For $8 Billion
Salesforce (CRM) is buying cloud data management firm Informatica (INFA) in an $8 billion U.S. deal that will bolster its push into artificial intelligence (A.I.).Under terms of the deal, holders of Informatica’s Class A and Class B-1 common stock will receive $25 U.S. in cash per share. Salesforce specializes in customer relationship management software and said that it plans to combine Informatica’s data catalog, integration, governance, privacy and data management services with its agentic AI solution, dubbed Agentforce.In a news release, Salesforce wrote: “Truly autonomous, trustworthy AI agents need the most comprehensive understanding of their data. The combination of Informatica’s advanced catalog and metadata capabilities with our Agentforce platform delivers exactly this.”Salesforce said it will fund the purchase through a combination of cash and debt. The purchase of Informatica is subject to regulatory approval. Shares of Salesforce are up about 1% in U.S. premarket trading on news of the Informatica purchase. Year-to-date, its share price has declined 17% to $273.13 U.S.The stock of Informatica is up 6% on news it is being acquired. So far this year, Informatica stock has fallen 11% to trade at $22.55 U.S. a share.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


